{
    "SPADE_UN_13852": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13852",
            "Peptide Name": "P4(SARS-CoV (1153–1182))",
            "Source": "Synthetic construct",
            "Family": "Coronaviridae",
            "Gene": "Not found",
            "Sequence": "GINASVVNIQKEIDRLNEVAKNLNESLIDL",
            "Sequence Length": 30,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P59594"
            ],
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.18983873]SARS-CoV:inhibition of cell fusion in Hela cells (IC50=0.80 ± 0.21 μM);inhibition of SARS-CoV infection in Vero-E6 cells (IC50=3.17 ± 0.24 μM).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "[Ref.18983873]No discernable cytotoxicity on HeLa or VeroE6 cells at the concentrations of 25 μM.",
            "Binding Target": "membrane",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C143H245N41O49",
            "Mass": 3322.72,
            "PI": 4.51,
            "Net Charge": -2,
            "Hydrophobicity": -0.11,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Mechanism of action": "Binding to the HR1 region and blocking the formation of  a 6-helix bundle during the fusion step of virus entry, thus inhibiting virus entry.",
            "Literature": [
                {
                    "Title": "Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.",
                    "Pubmed ID": "18983873",
                    "Reference": "Antiviral Res. 2009 Jan;81(1)82-7.",
                    "Author": "Liu IJ, Kao CL, Hsieh SC, Wey MT, Kan LS, Wang WK.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=18983873"
                }
            ],
            "Frequent Amino Acids": "NIL",
            "Absent Amino Acids": "CFHMOPTUWY",
            "Basic Residues": 3,
            "Acidic Residues": 5,
            "Hydrophobic Residues": 13,
            "Polar Residues": 16,
            "Positive Residues": 3,
            "Negative Residues": 5,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_13518",
                    "Similarity": 1.0,
                    "Sequence": "DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL"
                },
                {
                    "SPADE_ID": "SPADE_UN_13521",
                    "Similarity": 1.0,
                    "Sequence": "ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL"
                },
                {
                    "SPADE_ID": "SPADE_UN_13522",
                    "Similarity": 1.0,
                    "Sequence": "ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELK"
                }
            ]
        }
    }
}